Tsumuro Tae, Alejandra Hossen Maria, Kishi Yuko, Fujii Yoko, Kamei Chiaki
Department of Medicinal Pharmacology, Okayama University Graduate School of Medicine, Dentistry and Pharmaceutical Sciences, Okayama 700-8530, Japan.
Int Immunopharmacol. 2006 May;6(5):759-63. doi: 10.1016/j.intimp.2005.11.009. Epub 2005 Dec 6.
The aim of this study was to develop and characterize a new model for evaluating nasal congestion in rats by using whole body plethysmography (WBP)-free moving application. Brown Norway rats were sensitized with 10% toluene-2, 4-diisocyanate (TDI) solution, and nasal congestion was provoked with 5% TDI. An increase in the enhanced pause (Penh) was recognized after being challenged with TDI. In addition, a significant increase in the Penh was observed following the intranasal application of histamine in TDI sensitized rats. Histamine H1 antagonists, such as chlorpheniramine and ketotifen suppressed the increase of Penh during the early-phase response. On the other hand, epinastine suppressed the increase of Penh in both the early and late phase responses. In conclusion, we developed an allergic rhinitis model that includes nasal congestion symptoms in Brown Norway rats, and this model may be useful for evaluating the effects of drugs on nasal congestion.
本研究的目的是通过使用无全身体积描记法(WBP)的自由移动应用来开发和表征一种评估大鼠鼻充血的新模型。用10%甲苯-2,4-二异氰酸酯(TDI)溶液致敏棕色挪威大鼠,并用5% TDI诱发鼻充血。用TDI激发后可观察到增强间歇(Penh)增加。此外,在TDI致敏大鼠鼻内应用组胺后,Penh显著增加。组胺H1拮抗剂,如氯苯那敏和酮替芬在早期反应期间抑制Penh的增加。另一方面,依匹斯汀在早期和晚期反应中均抑制Penh的增加。总之,我们开发了一种在棕色挪威大鼠中包括鼻充血症状的变应性鼻炎模型,该模型可能有助于评估药物对鼻充血的影响。